Nephrology Feature Archive
Researchers are pursuing several strategies to engineer replacement kidney tissue.
Data that shed light on the allograft decision process may ultimately help transplant teams navigate their expanding waiting lists.
A low-protein diet, for example, may slow disease progression.
Staff shortages and lack of medical records surface as problems.
To avoid CKD, the guidelines now provide detailed review of the risk/benefit profile comparing partial to radical nephrectomy.
Data from MagnaSafe suggest that MRIs for patients with pacemakers/ICDs can be performed safely.
World Kidney Day 2017 promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that makes preventive behaviors an affordable option.
Efforts should be directed at making nephrology more appealing to recruit more trainees.
Ongoing studies are now looking at pharmacogenetics when comparing mycophenolate mofitil and cyclophosphamide for treating lupus nephritis.
The availability of direct-acting antiviral drugs may enable eradication of hepatitis C virus and improve outcomes.
It is unclear to physicians why some patients develop calciphylaxis while others do not.
As the rate of acceleration in ESRD incidence decline, physicians should expect heightened battles for the ESRD fountains.
Fellowship positions go unfilled as the US faces expanding population of kidney disease patients.
The end-stage renal disease community can now capture data on depression screening and pain assessment efforts.
The new consensus statement reflects the advances made in glucose monitoring technology and offers guidance for clinicians.
Ferric pyrophosphate citrate may play a role in the therapeutic armamentarium for dialysis patients.
We may feel good treating a patient's edema, but is fluid retention always harmful?
Low testosterone in men with CKD should not be treated routinely, but can be considered on an individual basis in some cases.
End-of-life considerations are increasingly influencing the course of dialysis in patients with end-stage renal disease.
FGF-23 may improve assessment of phosphate balance, but too many questions remain unanswered.
As the nephrology community grapples with a wide range of issues, Renal & Urology News (RUN) turned to Jonathan Himmelfarb, MD, Chair of the Public Policy Board at the American Society of Nephrology (ASN), for some perspective.
Researcher Macaulay Onuigbo, MD, MSc, proposes that ACE inhibitors and angiotensin receptor blockers can cause renal failure.
Continuous and intermittent renal replacement therapies for patients with acute kidney injury (AKI) are associated with similar outcomes, data show.
Agreement on what are normal values in medicine often is a prerequisite to the development of clinical guidelines. But what happens if guidelines are based on arguable definitions of normal?
Renal and Urology News Articles
- Testosterone Prescribing Declining in the US
- FDA Requires Safety Label Changes for Fluoroquinolones
- Robotic Partial Nephrectomy Mostly Superior to Other Surgeries
- Apixaban Is Safest Direct Oral Anticoagulant vs Warfarin
- Development of Clinically Evident Gout: A Closer Look at Elevated Serum Urate Levels
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)